DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Steg PG, Mehta SR, Jukema JW. et al.
RUBY-1: A randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.

Eur Heart J 2011;
32: 2541-2554.

Download Bibliographical Data

Search in:
Access: